Protective role of ETA endothelin receptors during the acute phase of Trypanosoma cruzi infection in rats

Microbes and Infection

Volumn 6, Issue 7, 2004, Pages 650-656

  Camargos, Elizabeth R S ^a   Rocha, Lamara L V ^a,c   Rachid, Milene A ^a   Almeida, Alvair P ^a   Ferreira, Anderson J ^a   Teixeira Jr , Antonio L ^a   Chiari, Egler ^a   Barton, Matthias ^b   Teixeira, Mauro M ^a   Machado, Conceição R S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Fund Educacional de Caratinga   (Brazil)

Author keywords

Chagas' disease; Coronary flow; Endothelin; Inflammation; Parasite clearance

Indexed keywords

BSF 461314; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; DARUSENTAN; PHENYLPROPIONIC ACID DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIAPHRAGM; ENDOTHELIUM LESION; EXPERIMENTAL INFECTION; HISTOLOGY; INFECTION PREVENTION; INFLAMMATION; ISOLATED HEART; MALE; NONHUMAN; PARASITE CONTROL; PARASITEMIA; PARASITISM; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; TRYPANOSOMA CRUZI; VASODILATATION; ACUTE DISEASE; ANIMAL; BLOOD FLOW VELOCITY; CHEMISTRY; DISEASE MODEL; DRUG ANTAGONISM; HEART; HUMAN; METABOLISM; PARASITOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

ACUTE DISEASE; ANIMALS; BLOOD FLOW VELOCITY; CHAGAS DISEASE; DISEASE MODELS, ANIMAL; HEART; HUMANS; INFLAMMATION; MALE; PARASITEMIA; PHENYLPROPIONATES; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; TRYPANOSOMA CRUZI;

EID: 2442714771     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.03.002     Document Type: Article

References (35)

1. Köberle F. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv. Parasitol. 6:1968;63-116
2. Tanowitz H.B., Kirchhoff L.V., Simon D., Morris S.A., Weiss L.M., Wittner M. Chagas' disease. Clin. Microbiol. Rev. 5:1992;400-419
3. Monteón V.M., Furuzawa-Carballeda J., Alejandre-Aguilar R., Aranda-Fraustro A., Rosales-Encina J.L., Reyes P.A. American trypanosomiasis: in situ and generalized features of parasitism and inflammatory kinetics in a murine model. Exp. Parasitol. 83:1996;267-274
4. Maldonado I.R.S.C., Ferreira M.L., Camargos E.R.S., Chiari E., Machado C.R.S. Skeletal muscle regeneration and Trypanosoma cruzi infection in rats. Histol. Histopathol. 19:2004;85-93
5. Kierszenbaum F. Chagas' disease and autoimmunity hypothesis. Clin. Microbiol. Rev. 12:1999;210-223
6. Soares M.B.P., Silva-Mota K.N., Lima R.S., Bellintani M.C., Pontes-de-Carvalho L., Ribeiro-dos-Santos R. Modulation of chagasic cardiomyopathy by interlekin-4. Am. J. Pathol. 159:2001;703-709
7. Morris S.A., Tanowitz H.B., Wittner M., Bilezikian J.P. Pathophysiological insights into the cardiomyopathy of Chagas' disease. Circulation. 82:1990;1900-1909
8. Rossi M.A. Microvascular changes as a cause of chronic cardiomyopathy in Chagas disease. Am. Heart J. 120:1990;233-236
9. Marin-Neto J.A., Marzullo P., Marcassa C., Gallo L., Maciel B.C., Bellina C.R., L'Abatte A. Myocardial perfusion abnormalities in chronic Chagas' disease as detected by thalium-201 scintigraphy. Am. J. Cardiol. 69:1992;780-784
10. Miyauchi T., Masaki T. Pathophysiology of endothelin in the cardiovascular system. Ann. Rev. Physiol. 61:1999;391-415
11. Cheng T.-H., Cheng P.-Y., Shih N.-L., Chen I.-B., Wang D.L., Chen J.-J. Involvement of reactive oxygen species in angiotensina II-induced endothelin-1 gene expression in rat cardiac fibroblast. J. Am. Coll. Cardiol. 42:2003;1845-1854
12. Yanagisawa Kurihara M.H., Kimura S., Tomobe Y., Kobayaski M., Mitsui Y., Goto K., Masaki T. A novel potent vasoconstriction peptide produced by vascular endothelial cells. Nature. 332:1988;411-415
13. Zhang Y., Oliver J.R., Horowitz J.D. Endothelin B receptor-mediated vasconstriction induced by endothelin A receptor antagonist. Cardiovasc. Res. 39:1998;665-673
14. Giannessi D., Del Ry S., Vitale R.L. The role of endothelin and their receptors in heart failure. Pharmacol. Res. 43:2001;111-126
15. Solomone O.A., Caeiro T.F., Madoery R.J., Amuchástegui M., Omelinauk M., Juri D., Kaski J.C. High plasma immunoreactive endothelin levels in patients with Chagas' cardiomyopathy. Am. J. Cardiol. 87:2001;1217-1220
16. Wittner M., Christ G.J., Huang H., Weiss L.M., Hatcher V.B., Morris S.A., Orr G.A., Berman J.W., Zeballos G.A., Douglas S.A. Trypanosoma cruzi induces endothelin release from endothelial cells. J. Infect. Dis. 171:1995;493-497
17. Tanowitz H.B., Burns E.R., Sinha A.K., Kahn N.N., Morris S.A., Factor S.M., Hatcher V.B., Bilezikian J.P., Baum S.G., Wittner M. Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy. Am. J. Trop. Med. Hyg. 43:1990;274-281
18. Tanowitz H.B., Kaul D.K., Chen B., Morris S.A., Factor S.M., Weiss L.M., Wittner M. Compromised microcirculation in acute murine Trypanosoma cruzi infection. J. Parasitol. 82:1996;124-130
19. Tanowitz H.B., Wittner M., Morris S.A., Zhao W., Weiss L.M., Hatcher V.B., Braunstein V., Huang H., Douglas S.A., Valcic M., Spektor M., Christ G.J. The putative mechanistic basis for the modulatory role of endothelin-1 in the altered vascular tone induced by Trypanosoma cruzi. Endothelium. 6:1999;217-230
20. Petkova S.B., Huang H., Factor S.M., Pestell R.G., Bouzahzah B., Jelicks L.A., Weiss L.M., Douglas S.A., Wittner M., Tanowitz H.B. The role of endothelin in the pathogenesis of Chagas' disease. Int. J. Parasitol. 31:2001;499-511
21. Machado C.R.S., Ribeiro A.L.P. Experimental American trypanosomiasis in rats: sympathetic denervation, parasitism and inflammatory process. Mem. Inst. Oswaldo Cruz. 84:1989;549-556
22. Riechers H., Albrecht H.P., Amberg W., Baumann E., Bernard H., Bohn H.J., Klinge D., Kling A., Muller S., Raschack M., Unger L., Walker N., Wernet W. Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists. J. Med. Chem. 39:1996;2123-2128
23. Melo R.C.N., Machado C.R.S. Depletion of radiosensitive leukocytes exacerbates the heart sympathetic denervation in experimental Chagas' disease in rats. J. Neuroimmunol. 84:1998;151-157
24. Brener Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev. Inst. Med. Trop. São Paulo. 4:1962;380-396
25. Camargos E.R.S., Franco D.J., Garcia C.M.G., Dutra A.P., Teixeira A.L. Jr, Chiari E., Machado C.R.S. Infection with different Trypanosoma cruzi populations in rats: myocarditis, cardiac sympathetic denervation, and involvement of digestive organs. Am. J. Trop. Med. Hyg. 62:2000;604-612
26. Cottle M.K.W., Cottle W.H., Pérusse F., Bukowiecki L. An improved glyoxylic acid technique for the histochemical localization of catecholamines in brown adipose tissue. Histochem. J. 17:1985;1279-1288
27. Tippins J.R., Antoniw J.W., Maseri A. Endothelin-1 is a potent constrictor in conductive and resistive coronary arteries. J. Cardiovasc. Pharmacol. 13:(Suppl. 5):1989;S177-S179
28. Barton M. Endothelial dysfunction and atherosclerosis: endothelin receptor antagonists as novel therapeutics. Curr. Hypertension Rep. 2:2000;84-91
29. Stoyneva Z., Lyapina M., Tzvetkov D., Vodenicharov E. Current pathophysiological views on vibration induced Raynaud' s phenomenon. Cardiovasc. Res. 57:2003;615-624
30. Piatti P.M., Fragasso G., Monti L.D., Setola E., Lucotti P., Fermo I., Paroni R., Galluccio E., Pozza G., Chierchia S., Margonato A. Acute intravenous L-arginine decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms. Correlation with asymmetric dimethylarginina levels. Circulation. 107:2003;429-436
31. Ohnishi M., Wada A., Tsutamoto T., Fujii M., Matsumoto T., Yamamoto T., Takayama T., Wang X., Kinoshita M. Endothelin stimulates and endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginin, in experimental heart failure. Clin. Sci. 103:(Suppl. 48):2002;241S-244S
32. Rae G.A., Henriques M.G.M.O. Endothelins in inflammation. Said S.M. Proinflammatory and Antiinflammatory peptides. 1998;163-202 Marcel Decker, New York
33. Wanecek M., Weitzberg E., Rudehill A., Oldner A. The endothelin system in septic and endotoxin shock. Eur. J. Pharmacol. 407:2000;1-15
34. Sampaio A.L., Rae G.A., Henriques M.M. Role of endothelins on lymphocyte accumulation in allergic pleurisy. J. Leukoc. Biol. 67:2000;189-195
35. Usui M., Matsuoka H., Miyazaki H., Ueda S., Okuda S., Imaizumi T. Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci. 62:1998;3425-3430